The World Smells Different in Parkinsons Disease
Andelman-Gur, M. M.; Shushan, S.; Snitz, K.; Pinchasof, G.; Honigstein, D.; Gorodisky, L.; Ravia, A.; Ezra, A.; Hezi, N.; Gurevich, T.; Sobel, N.
Show abstract
Olfactory decline is a well-established aspect of Parkinsons disease (PD) and is considered one of its earliest signs, often preceding motor symptoms by years to decades. However, because olfactory impairment is also common in healthy aging and other medical conditions, current olfactory tests that score performance (odor detection, discrimination, and identification) lack disease specificity. In contrast to performance scores, olfactory perceptual fingerprints are derived from odor ratings and sniffing behavior, and provide a stable measure of how the world smells to an individual. To test the hypothesis that olfactory perceptual fingerprints may provide a disease-specific marker, we obtained them in three cohorts: Individuals with PD (n=33), healthy age-matched controls (n=33), and critically, in participants with non-PD olfactory dysfunction (n=28). Consistent with previous results, a standard clinical olfactory test detected impairment in both PD and non-PD olfactory dysfunction, but failed to distinguish between these two groups. In contrast, olfactory perceptual fingerprints detected impairment, and distinguished PD from non-PD olfactory dysfunction at 88% accuracy (SVM classification, leave-one-out cross validation, 90% sensitivity, 85% specificity, P=3.2x10-4), or 94% accuracy after matching age and sex (SVM classification, leave-one-out cross-validation, 100% sensitivity, 88% specificity, P=0.0047). The difference between PD related and unrelated olfactory decline was particularly evident in sniffing behavior: Whereas both healthy participants and non-PD olfactory decline groups decreased sniff duration in response to unpleasant odors (-12.5% and -11.36% respectively), individuals with PD paradoxically increased sniff duration (+1.69%; P=4.5x10-5). Thus, PD was marked not by loss of olfactory performance, but by a distinct shift in olfactory perception. These findings imply that olfactory perceptual fingerprints provide for a disease-specific marker in PD.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis 88%
- COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis 88%
- Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of Huntington's disease 87%
Similar papers in this journal
- Genetic Analysis and Natural History of Parkinson’s Disease Due to the LRRK2 G2019S Variant 92%
- Mapping the peripheral immune landscape of Parkinson's disease patients with single-cell sequencing 92%
- Neuronal titration of Snca via enhancer disruption mitigates disease onset in a Parkinson's disease mouse model 91%
Similar papers in this journal
- Lysosomal Glucocerebrosidase is needed for ciliary Hedgehog signaling: A convergent pathway to Parkinsons disease 90%
- Natural Variation in Age-Related Dopamine Neuron Degeneration is Glutathione-Dependent and Linked to Life Span 90%
- Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinsons disease 90%
Similar papers in this journal
- Semiochemical responsive olfactory sensory neurons are sexually dimorphic and plastic 91%
- Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration 91%
- Altered reactivity to threatening stimuli in Drosophila models of Parkinson's disease, revealed by a trial-based assay 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.